Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  Promis Neurosciences Inc    PMN   CA74346M1095

PROMIS NEUROSCIENCES INC

(PMN)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
06/13/2019 06/14/2019 06/17/2019 06/18/2019 06/19/2019 Date
0.26(c) 0.245(c) 0.26(c) 0.255(c) 0.25 Last
137 880 83 846 47 310 38 500 38 374 Volume
+1.96% -5.77% +6.12% -1.92% -1.96% Change
More quotes
Financials (CAD)
Sales 2019 6,67 M
EBIT 2019 -4,77 M
Net income 2019 -4,77 M
Debt 2019 -
Yield 2019 -
Sales 2020 25,0 M
EBIT 2020 10,8 M
Net income 2020 10,8 M
Debt 2020 -
Yield 2020 -
P/E ratio 2019 -
P/E ratio 2020 4,32
Capi. / Sales2019 9,43x
Capi. / Sales2020 2,52x
Capitalization 62,9 M
More Financials
Company
ProMIS Neurosciences Inc, formerly Amorfix Life Sciences Ltd, is a Canada-based development-stage biotech company. The Company discovers and develops precision therapeutics with companion diagnostics for early detection and treatment of neurodegenerative diseases, in particular Alzheimer's disease... 
Sector
Biotechnology & Medical Research
Calendar
06/27 | 09:00amShareholder meeting
More about the company
Surperformance© ratings of Promis Neurosciences Inc
Trading Rating : Investor Rating : -
More Ratings
Latest news on PROMIS NEUROSCIENCES INC
07:31aPROMIS NEUROSCIENCES : Appoints Renowned Parkinson's Disease Expert Dr. C. Warre..
AQ
07:31aProMIS Neurosciences Appoints Renowned Parkinson's Disease Expert Dr. C. Warr..
GL
06/05PROMIS NEUROSCIENCES : Presents Lead Program for Alzheimer's Disease at Prestigi..
PR
06/05ProMIS Neurosciences Presents Lead Program for Alzheimer's Disease at Prestig..
GL
05/30PROMIS NEUROSCIENCES : Eugene Williams to Present at JLABS Conference on Innovat..
AQ
05/29PROMIS NEUROSCIENCES' : Eugene Williams to Present at JLABS' Conference on Innov..
PR
05/29ProMIS Neurosciences' Eugene Williams to Present at JLABS' Conference on Inno..
GL
05/28PROMIS NEUROSCIENCES : Identifies Novel Antibodies for Alzheimer's Disease with ..
AQ
05/28PROMIS NEUROSCIENCES : Identifies Novel Antibodies for Alzheimer's Disease with ..
PR
05/14PROMIS NEUROSCIENCES : Announces First Quarter 2019 Results
PR
More news
Sector news : Bio Therapeutic Drugs
06/18WHAT'S NEWS : Business & Finance -- WSJ
DJ
06/18PFIZER : Expands Cancer-Treatment Lineup
DJ
06/17ARRAY BIOPHARMA : Pfizer makes $10.6 billion cancer bet in cash deal for Array B..
RE
06/17PFIZER : to Buy Array BioPharma in $10.64 Billion Deal -- 4th Update
DJ
06/17Voyager Therapeutics Up 9%; Restructures Relationship with Sanofi Genzyme
DJ
More sector news : Bio Therapeutic Drugs
Chart PROMIS NEUROSCIENCES INC
Duration : Period :
Promis Neurosciences Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PROMIS NEUROSCIENCES INC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Average target price 0,55  CAD
Spread / Average Target 124%
EPS Revisions
Managers
NameTitle
Elliot Goldstein President, Chief Executive Officer & Director
Eugene Williams Executive Chairman
Daniel E. Geffken Chief Financial Officer
Neil R. Cashman Director & Chief Scientific Officer
James Kupiec Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
PROMIS NEUROSCIENCES INC-3.70%52
GILEAD SCIENCES7.27%80 909
VERTEX PHARMACEUTICALS4.87%42 680
REGENERON PHARMACEUTICALS-16.74%32 744
GENMAB13.49%10 857
SAREPTA THERAPEUTICS INC21.25%8 523